{"id":"W2569292446","doi":"10.1182/blood.v116.21.2454.2454","title":"Fludarabine and Rituximab (FR) Is a Safe and Effective Treatment Alternative for Relapsed or Refractory Hairy Cell Leukemia (HCL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Fludarabine; Medicine; Cladribine; Rituximab; Tolerability; Internal medicine; Gastroenterology; Refractory (planetary science); Neutropenia; Surgery; Oncology; Lymphoma; Adverse effect; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002594628,0.00007647911,0.0002394909,0.000348753,0.0001580549,0.0002349583,0.0002492542,0.000247535,0.001701284],"category_scores_gemma":[0.0003545585,0.00005615663,0.0001257376,0.000371922,0.0001361082,0.0001392765,0.0001168226,0.000173515,0.0002531588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005866938,"about_ca_system_score_gemma":0.0005744102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003221121,"about_ca_topic_score_gemma":0.01502441,"domain_scores_codex":[0.9998549,0.00003681994,0.00001446821,0.00001997959,0.00005115844,0.00002270415],"domain_scores_gemma":[0.9998406,0.00003697064,0.00006966551,0.000007203995,0.00001384438,0.00003179182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005425804,0.0005453584,0.1469064,0.001085814,0.0002729942,0.007641988,0.0001564621,0.000613013,0.02664344,0.0003867417,0.01317687,0.7971451],"study_design_scores_gemma":[0.003254384,0.008398299,0.8495401,0.0005703188,0.000383952,0.04223709,0.0002862016,0.001796452,0.005470757,0.0004506315,0.08757088,0.00004097034],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9167628,0.07103345,0.0006006417,0.001119811,0.00005423367,0.0001358743,0.0007689162,0.00009166227,0.009432592],"genre_scores_gemma":[0.9910197,0.006028338,0.0005023311,0.0004303955,0.00004582888,0.00002243542,0.0008188591,0.000003243554,0.001128935],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003221121,"threshold_uncertainty_score":0.006404757,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01413825424014396,"score_gpt":0.2961666336456449,"score_spread":0.282028379405501,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}